BioMerieux Recalls ETEST Tobramycin Strips Due to Stability Issues
BioMerieux SA is recalling ETEST Tobramycin antimicrobial susceptibility testing strips because their shelf-life claims are not supported by internal testing.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the hazard is a stability/shelf-life issue without reported injuries or illnesses, fitting the criteria for a moderate severity precautionary recall.
Plain-English summary
BioMerieux SA is recalling specific lots of ETEST Tobramycin TM256 FOAM packaging (Reference no. 522718 and 522758). The recall is due to product stability issues, as the current shelf-life claims for these ETEST products are not supported by internal testing.
The affected products are used to determine the antimicrobial susceptibility of various bacteria. The recall covers specific lot numbers: 1001761650, 1002112440, 1002860460, 1005166530, 1001888970, 1002281590, and 1003590490. The products were distributed worldwide, including in the United States and numerous foreign countries.
Users should stop using the affected lots and contact BioMerieux SA for further instructions.
The recalled product
- Product
- ETEST Tobramycin TM256 FOAM packaging, Product Name: ETEST Tobramycin TM 0.016-256(low). ETEST is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria such as Enterobacteriaceae, Pseudomonas…
- Manufacturer
- BioMerieux SA
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Reference no. 522718
- Lot #1001761650
- 1002112440
- 1002860460 & 1005166530 and Reference no. 522758
- Lot #1001888970
- 1002281590 & 1003590490.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 12 recalled by BioMerieux SA under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · BioMerieux SA
See all →- HighMYLA Diagnostic System Software Versions Recalled for Risk of False Negatives
FDA (Devices) · 2021-10-20
- HighMYLA Laboratory Software: Potential Test Result Alteration from Software Anomaly
FDA (Devices) · 2021-08-18
- ModerateBioMerieux NucliSENS Magnetic Extraction Reagents Recalled Due to Temperature Exposure
FDA (Devices) · 2018-10-31
- ModerateBioMerieux Recalls VIDAS FSH Assay Kits Due to Calibration Issues
FDA (Devices) · 2018-07-04
- ModerateBioMérieux Recalls VITEK 2 Gram-Positive Cards Due to Temperature Excursion
FDA (Devices) · 2018-06-20
Same hazard · stability issue
See all →- Moderate5-PLASMA Bivalirudin Control Model 5D-44905 Recalled Due to Stability Issues
FDA (Devices) · 2026-08-12
- ModerateAniara 5-PLASMA Bivalirudin Calibrator Recalled for Stability Issues
FDA (Devices) · 2026-08-12
- HighInjectable Drug Recalled for Stability Issues at Expiration
FDA (Drugs) · 2025-03-26
- ModerateMedline Bleach Germicidal Wipes Recalled for Incorrect Shelf-Life Labeling
FDA (Devices) · 2024-02-28
- ModerateZydus oxybutynin extended-release tablets recalled nationwide for failed stability testing
FDA (Drugs) · 2023-11-15
Similar recalls
- ModerateBioMerieux ETEST XM256 Cefuroxime Recalled for Potential Performance Issues
FDA (Devices) · 2017-03-01
- HighETEST Tobramycin Susceptibility Test Recalled for Storage Condition Failure
FDA (Devices) · 2023-01-11
- HighBioMerieux Recalls ETEST ETP32 Ertapenem Strips Due to False Results
FDA (Devices) · 2017-05-24
- ModerateBioMerieux Recalls Ceftriaxone ETEST Kits Due to Performance Issues
FDA (Devices) · 2017-05-31
- CriticalBiomerieux Etest PIP/TAZO/CON-4 PTC 256 Recalled for Erroneous Results
FDA (Devices) · 2015-12-30
- SevereBiomerieux Recalls Etest PIP/TAZO/CON-4 PTC 256 Antimicrobial Susceptibility Tests
FDA (Devices) · 2015-12-30